About NRx
NRx is a company based in Wilmington (United States) founded in 2017 by Daniel C Javitt and Jonathan C Javitt.. NRx operates in a competitive market with competitors including Pardes Biosciences, Vaxxinity, ExeVir Bio, Inimmune and IMUNON, among others.
- Headquarter Wilmington, United States
- Founders Daniel C Javitt, Jonathan C Javitt
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nrx Pharmaceuticals, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-25.13 M16.66as on Dec 31, 2024
-
EBITDA
$-19.7 M28.58as on Dec 31, 2024
-
Latest Funding Round
$25 M (USD), Post-IPO
Feb 02, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NRx
NRx is a publicly listed company on the NASDAQ with ticker symbol NRXP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of NRx
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $25.0M
-
First Round
First Round
(01 Feb 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Post-IPO - NRx | Valuation |
investors |
|
| Aug, 2021 | Amount | Post-IPO - NRx | Valuation |
investors |
|
| Feb, 2017 | Amount | Grant - NRx | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NRx
NRx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NRx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NRx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nrx Comparisons
Competitors of NRx
NRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pardes Biosciences, Vaxxinity, ExeVir Bio, Inimmune and IMUNON, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for pandemic diseases including SARS-CoV-2 are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines for neurological disorders and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of antibody-based therapies to monitor viral infections
|
|
| domain | founded_year | HQ Location |
Integrated clinical developmental services to treat food allergy, allergic rhinitis, and auto-immune disorders
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed using DNA-based platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nrx
Frequently Asked Questions about NRx
When was NRx founded?
NRx was founded in 2017.
Where is NRx located?
NRx is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Who is the current CEO of NRx?
Jonathan C Javitt is the current CEO of NRx. They have also founded this company.
What does NRx do?
NRx was founded in 2017 and is headquartered in Wilmington, United States. Therapeutics targeting COVID-19 and neurological disorders are developed by the company within the pharmaceutical sector. Operations focus on candidates such as ZYESAMI, which contains aviptadil acetate for respiratory failure in COVID-19, along with NRX-101 and NRX-100 for acute suicidal behavior in bipolar disorder. Clinical development and regulatory processes are managed from the U.S. base.
Who are the top competitors of NRx?
NRx's top competitors include ExeVir Bio, Cell BioEngines and Pardes Biosciences.
Is NRx publicly traded?
Yes, NRx is publicly traded on NASDAQ under the ticker symbol NRXP.
Who are NRx's investors?
NRx has 1 investor. Key investors include HHS.
What is NRx's ticker symbol?
The ticker symbol of NRx is NRXP on NASDAQ.
What is NRx's valuation?
The valuation of NRx is $1.5B as of Aug 2021.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.